Literature DB >> 21739155

Structural and functional determinants of protein kinase CK2α: facts and open questions.

Roberto Battistutta1, Graziano Lolli.   

Abstract

Ser/Thr protein kinase CK2 is involved in several fundamental processes that regulate the cell life, such as cell cycle progression, gene expression, cell growth, and differentiation and embryogenesis. In various cancers, CK2 shows a markedly elevated activity that has been associated with conditions that favor the onset of the tumor phenotype. This prompts to numerous studies aimed at the identification of compounds that are able to inhibit the catalytic activity of this oncogenic kinase, in particular, of ATP-competitive inhibitors. The many available crystal structures indicate that this enzyme owns some regions of remarkable flexibility which were associated to important functional properties. Of particular relevance is the flexibility, unique among protein kinases, of the hinge region and the following helix αD. This study attempts to unveil the structural bases of this characteristic of CK2. We also analyze some controversial issues concerning the functional interpretation of structural data on maize and human CK2 and try to recognize what is reasonably established and what is still unclear about this enzyme. This analysis can be useful also to outline some principles at the basis of the development of effective ATP-competitive CK2 inhibitors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21739155     DOI: 10.1007/s11010-011-0939-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Inhibition of protein kinase CK2 by anthraquinone-related compounds. A structural insight.

Authors:  Erika De Moliner; Stefano Moro; Stefania Sarno; Giuseppe Zagotto; Giuseppe Zanotti; Lorenzo A Pinna; Roberto Battistutta
Journal:  J Biol Chem       Date:  2002-11-04       Impact factor: 5.157

2.  Structural basis of CX-4945 binding to human protein kinase CK2.

Authors:  Andrew D Ferguson; Payal R Sheth; Andrea D Basso; Sunil Paliwal; Kimberly Gray; Thierry O Fischmann; Hung V Le
Journal:  FEBS Lett       Date:  2010-11-18       Impact factor: 4.124

Review 3.  Conformational plasticity of the catalytic subunit of protein kinase CK2 and its consequences for regulation and drug design.

Authors:  Karsten Niefind; Olaf-Georg Issinger
Journal:  Biochim Biophys Acta       Date:  2009-09-28

Review 4.  Addiction to protein kinase CK2: a common denominator of diverse cancer cells?

Authors:  Maria Ruzzene; Lorenzo A Pinna
Journal:  Biochim Biophys Acta       Date:  2009-08-06

5.  The ATP-binding site of protein kinase CK2 holds a positive electrostatic area and conserved water molecules.

Authors:  Roberto Battistutta; Marco Mazzorana; Laura Cendron; Andrea Bortolato; Stefania Sarno; Zygmunt Kazimierczuk; Giuseppe Zanotti; Stefano Moro; Lorenzo A Pinna
Journal:  Chembiochem       Date:  2007-10-15       Impact factor: 3.164

6.  Inclining the purine base binding plane in protein kinase CK2 by exchanging the flanking side-chains generates a preference for ATP as a cosubstrate.

Authors:  Christina W Yde; Inessa Ermakova; Olaf-Georg Issinger; Karsten Niefind
Journal:  J Mol Biol       Date:  2005-01-18       Impact factor: 5.469

7.  Structural features underlying selective inhibition of protein kinase CK2 by ATP site-directed tetrabromo-2-benzotriazole.

Authors:  R Battistutta; E De Moliner; S Sarno; G Zanotti; L A Pinna
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

Review 8.  Protein kinase CK2 in health and disease: Structural bases of protein kinase CK2 inhibition.

Authors:  R Battistutta
Journal:  Cell Mol Life Sci       Date:  2009-06       Impact factor: 9.261

Review 9.  A structural insight into CK2 inhibition.

Authors:  Marco Mazzorana; Lorenzo A Pinna; Roberto Battistutta
Journal:  Mol Cell Biochem       Date:  2008-07-15       Impact factor: 3.396

10.  Biochemical and three-dimensional-structural study of the specific inhibition of protein kinase CK2 by [5-oxo-5,6-dihydroindolo-(1,2-a)quinazolin-7-yl]acetic acid (IQA).

Authors:  Stefania Sarno; Erika de Moliner; Maria Ruzzene; Mario A Pagano; Roberto Battistutta; Jenny Bain; Doriano Fabbro; Joseph Schoepfer; Matthew Elliott; Pascal Furet; Flavio Meggio; Giuseppe Zanotti; Lorenzo A Pinna
Journal:  Biochem J       Date:  2003-09-15       Impact factor: 3.857

View more
  12 in total

1.  Mechanism of CK2 Inhibition by a Ruthenium-Based Polyoxometalate.

Authors:  Simone Fabbian; Gabriele Giachin; Massimo Bellanda; Christian Borgo; Maria Ruzzene; Giacomo Spuri; Ambra Campofelice; Laura Veneziano; Marcella Bonchio; Mauro Carraro; Roberto Battistutta
Journal:  Front Mol Biosci       Date:  2022-06-02

2.  Cross-species proteomics reveals specific modulation of signaling in cancer and stromal cells by phosphoinositide 3-kinase (PI3K) inhibitors.

Authors:  Vinothini Rajeeve; Iolanda Vendrell; Edmund Wilkes; Neil Torbett; Pedro R Cutillas
Journal:  Mol Cell Proteomics       Date:  2014-03-19       Impact factor: 5.911

3.  Casein kinase 2 (CK2) phosphorylates the deubiquitylase OTUB1 at Ser16 to trigger its nuclear localization.

Authors:  Lina Herhaus; Ana B Perez-Oliva; Giorgio Cozza; Robert Gourlay; Simone Weidlich; David G Campbell; Lorenzo A Pinna; Gopal P Sapkota
Journal:  Sci Signal       Date:  2015-04-14       Impact factor: 8.192

4.  Label-free quantitative analysis of the casein kinase 2-responsive phosphoproteome of the marine minimal model species Ostreococcus tauri.

Authors:  Thierry Le Bihan; Matthew Hindle; Sarah F Martin; Martin E Barrios-Llerena; Johanna Krahmer; Katalin Kis; Andrew J Millar; Gerben van Ooijen
Journal:  Proteomics       Date:  2015-06-09       Impact factor: 3.984

5.  Classifying kinase conformations using a machine learning approach.

Authors:  Daniel Ian McSkimming; Khaled Rasheed; Natarajan Kannan
Journal:  BMC Bioinformatics       Date:  2017-02-02       Impact factor: 3.169

6.  Unexpected Binding Mode of a Potent Indeno[1,2-b]indole-Type Inhibitor of Protein Kinase CK2 Revealed by Complex Structures with the Catalytic Subunit CK2α and Its Paralog CK2α'.

Authors:  Jennifer Hochscherf; Dirk Lindenblatt; Benedict Witulski; Robin Birus; Dagmar Aichele; Christelle Marminon; Zouhair Bouaziz; Marc Le Borgne; Joachim Jose; Karsten Niefind
Journal:  Pharmaceuticals (Basel)       Date:  2017-12-13

7.  Specific inhibition of CK2α from an anchor outside the active site.

Authors:  Paul Brear; Claudia De Fusco; Kathy Hadje Georgiou; Nicola J Francis-Newton; Christopher J Stubbs; Hannah F Sore; Ashok R Venkitaraman; Chris Abell; David R Spring; Marko Hyvönen
Journal:  Chem Sci       Date:  2016-07-12       Impact factor: 9.825

8.  Structural Hypervariability of the Two Human Protein Kinase CK2 Catalytic Subunit Paralogs Revealed by Complex Structures with a Flavonol- and a Thieno[2,3-d]pyrimidine-Based Inhibitor.

Authors:  Karsten Niefind; Nils Bischoff; Andriy G Golub; Volodymyr G Bdzhola; Anatoliy O Balanda; Andriy O Prykhod'ko; Sergiy M Yarmoluk
Journal:  Pharmaceuticals (Basel)       Date:  2017-01-11

9.  Second-generation CK2α inhibitors targeting the αD pocket.

Authors:  Jessica Iegre; Paul Brear; Claudia De Fusco; Masao Yoshida; Sophie L Mitchell; Maxim Rossmann; Laura Carro; Hannah F Sore; Marko Hyvönen; David R Spring
Journal:  Chem Sci       Date:  2018-02-20       Impact factor: 9.825

Review 10.  Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias.

Authors:  Alessandro Morotti; Giovanna Carrà; Cristina Panuzzo; Sabrina Crivellaro; Riccardo Taulli; Angelo Guerrasio; Giuseppe Saglio
Journal:  Adv Hematol       Date:  2015-12-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.